Epidemiology of Colorectal Cancer Revisited: Are Serum Triglycerides and/or Plasma Glucose Associated with Risk?

Cancer Epidemiology Biomarkers and Prevention

Volumn 3, Issue 8, 1994, Pages 687-695

  McKeown Eyssen, Gail ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; TRIACYLGLYCEROL;

CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

BILE ACIDS AND SALTS; BLOOD GLUCOSE; COLORECTAL NEOPLASMS; FEMALE; HUMAN; INSULIN; MALE; MODELS, BIOLOGICAL; RISK FACTORS; TRIGLYCERIDES;

EID: 0028113617     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (148)

1. Committee on Diet and Health. Diet and Health: Implications for Reducing Chronic Disease Risk. Washington DC: National Academy Press, 1989.
2. Committee on Diet, Nutrition and Cancer. Diet, Nutrition and Cancer. Washington DC: National Academy Press, 1982.
3. Potter, J. D., Slattery, M. L., Bostick, R. M., and Gapstur, S. M. Colon cancer: a review of the epidemiology. Epidemiol. Rev., 15: 499–545, 1993.
4. Willett, W. C., Stampfer, M. J., Colditz, G. A., Rosner, B. A., and Speizer, F. E. Relation of meat, fat and fibre intake to the risk of colon cancer in a prospective study among women. N. Engl. J. Med., 323: 1664–1672, 1990.
5. Giovannucci, E., Stampfer, M. J., Colditz, G., Rimm, E. B., and Willett, W. C. Relation of diet to the risk of colorectal adenoma in men. J. Natl. Cancer Inst., 15: 74–75, 1992.
6. Steinmetz, K. A., and Potter, J. D. Vegetables, fruit and cancer. II Mechanisms. Cancer Causes Control, 2: 427–442, 1991.
7. Policy Statement on Prevention of Colorectal Cancer by Diet. Toronto: Canadian Cancer Society, 1983.
8. American Cancer Society. New Dietary Guidelines. New York: American Cancer Society News Service, 1984.
9. European Organization for Cooperation on Cancer Prevention Studies and the International Union of Nutritional Sciences. Consensus Statement on Provisional Dietary Guidelines. Nutr. Cancer, 8: 39–40, 1986.
10. Statement of the National Cancer Institute. Office of Cancer Communications, Diet and Cancer, 1986.
11. Bostick, R. M., Potter, J. D., Kushi, L. H., Sellers, T. A., Steinmetz, K. A., McKenzie, D. R., Gapstur, S. M., and Folsom, A. R. Sugar, meat and fat intake, and nondietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control, 5: 38–52, 1994.
12. Lew, E. A., and Garfinkel, L. Variations in mortality by weight among 750,000 men and women. J. Chron. Dis., 32: 563–576, 1979.
13. Tartter, P. I., Slater, C., Paptestas, G., and Aufses, A. H. Cholesterol, weight, height, Quetelet's index and colon cancer recurrence. J. Surg. Oncol., 27: 232–235, 1984.
14. Albanes, D., and Taylor, P. R. International differences in body height and weight and their relationship to cancer incidence. Nutr. Cancer, 14: 69–77, 1990.
15. Albanes, D., Jones, D. Y., Schatzkin, A., and Micozzi, M. S. Adult stature and risk of cancer. Cancer Res., 48: 1658–1662, 1988.
16. Carroll, K. K. Biologic effects of fish oils in relation to chronic diseases. Lipids, 27: 731–732, 1986.
17. Mann, J. Complex carbohydrates: replacement of energy for fat or useful in their own right? Am. J. Clin. Nutr., 45: 1202–1206, 1987.
18. Truswell, A. S., and Mann, J. I. Epidemiology of serum lipids in Southern Africa. Artheriosclerosis, 76: 15–29, 1972.
19. Mann, J. Diabetes Melitus: some aspects of aetiology and management of noninsulin-dependent diabetes. In: H. Trowell, D. Burkitt, and K. Heaton (eds.), Dietary Fibre, Fibre Dependent Foods and Disease, pp. 263–287. London: Academic Press, 1985.
20. Brown, W. V., and Karmally, W. Coronary heart disease and consumption of diets high in wheat and other grains. Am. J. Clin. Nutr., 47: 1163–1171, 1985.
21. Antonis, A., and Bersohn, I. Influence of diet on serum triglycerides. Lancet, 3–9, 1961.
22. Hatch, J. T., Abell, L. L., and Kendall, F. E. Effects of restriction of fat and cholesterol upon serum lipids and lipoproteins in patients with hypertension. Am. J. Med., 79: 48–60, 1955.
23. Grundy, S. M. Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N. Engl. J. Med., 314: 745–749, 1986.
24. Coulston, A., Lui, G. C., and Reaven, G. M. Plasma glucose, insulin and lipid responses to high-carbohydrate low-fat diets in normal humans. Metabolism, 32: 52–56, 1983.
25. Lewis, B., Hammett, F., and Katan, M. Towards an improved lipid lowering diet: additive effects of changes in nutrient intake. Lancet, 2: 1310–1313, 1981.
26. Jenkins, D. J. A. Lente carbohydrate: a newer approach to dietary management of diabetes. Diabetes Care, 5: 634–639, 1982.
27. Anderson, J. W., Chen, W. J. L., and Sieling, B. Hypolipidemic effects of high carbohydrate high fibre diets. Metabolism, 29: 551–558, 1980.
28. Albrink, M. J., and Ullrich, I. H. Interaction of dietary sucrose and fiber on serum lipids in healthy young men fed high carbohydrate diets. Am. J. Clin. Nutr., 43: 419–428, 1986.
29. Karlstrom, B., Vessby, B., Asp, N. G., Boberg, M., Gustaffson, I. B., Lithell, H., and Werner, I. Effects of an increased content of cereal fibre in the diet of Type 2 (non-insulin dependent) diabetic patients. Diabetologia, 26: 272–277, 1984.
30. Aderson, J. W., Story, L., Sieling, R. D., Chen, W. J. L., Petro, M. S., and Story, J. Hypocholesterolemic effects of oat bran or bean intake for hyper- cholesterolemic men. Am. J. Clin. Nutr., 40: 1146–1155, 1984.
31. Bosello, O., Cominacini, L., Zocca, I., Garbin, U., Ferrari, F., and Davoli, A. Effects of guar gum on plasma lipoproteins and apolipoproteins C-II and C-III in patients affected by familial hyperlipoproteinemia. Am. J. Clin. Nutr., 40: 1165–1174, 1984.
32. Angelico, F., Clemente, P., Menoti, A., Ricci, G., and Urbinati, G. Bran and changes in serum lipids: observations during a project of primary prevention of coronary heart disease. In: L. A. Carlson (ed.), International Conference on Artherosclerosis, pp. 205–207. New York: Raven Press, 1978.
33. Riccardi, G., Rivellese, A., Pacioni, D., Genovese, S., Mastranzo, P., and Mancini, M. Separate influence of dietary carbohydrate and fibre on the metabolic control in diabetes. Diabetologia, 26: 116–121, 1984.
34. Hollenbeck, C. B., Coulston, A. M., and Reaven, G. M. To what extent does increased dietary fibre improve glucose and lipid metabolism in patients with noninsulin-dependent diabetes mellitus (NIDDM)? Am. J. Clin. Nutr., 43: 16–24, 1986.
35. Salvioli, G., Lugli, R., and Pradelli, J. M. Cholesterol absorption and sterol balance in normal subjects receiving dietary fibre or ursodeoxycholic acid. Dig. Dis. Sci., 30: 301–307, 1985.
36. Wahlquist, M. L. Dietary fibre and carbohydrate metabolism. Am. J. Clin. Nutr., 45: 1232–1236, 1987.
37. Miettinen, T. A. Dietary fibre and lipids. Am. J. Clin. Nutr., 45: 1237–1242, 1987.
38. Committee on Diet and Health. Diet and Health: Implications for Reducing Chronic Disease Risk, pp. 431–464. Washington DC: National Academy Press, 1989.
39. Gerard, M. J., Klatsky, A. L., Siegelaub, A. B., Friedman, G. D., and Feldman, R. Serum glucose levels and alcohol-consumption habits in a large population. Diabetes, 26: 780–785, 1977.
40. Ashley, F. W., and Kannel, W. B. Relation of weight change to changes in artherogenic traits: the Framingham Study, J. Chron. Dis., 27: 103–104, 1974.
41. Committee on Diet and Health. Diet and Health: Implications for Reducing Chronic Disease Risk, pp. 529–547. Washington DC: National Academy Press, 1989.
42. Committee on Diet and Health. Diet and Health: Implications for Reducing Chronic Disease Risk, pp. 563–592. Washington DC: National Academy Press, 1989.
43. Lapidas, L., Bengtsson, C., Larsson, B., Ponnert, K., Rypo, E., and Sjostrom, L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow-up of participants in the population study of women in Gothenburg, Sweden. Br. Med. J., 289: 1257–1261, 1984.
44. Bjorntorp, P. Adipose tissue in obesity (Willendorf lecture). In: J. Hirsch and T. B. Van Itallie (eds.), Recent Advances in Obesity Research. Vol 4, pp. 163–170. London: John Libbey, 1985.
45. Krotkiewski, M., Bjorntorp, P., Sjostrom, L., and Smith, U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J. Clin. Invest., 72: 1150–1162, 1983.
46. Hartz, R. J., Rupley, D. C., and Rimm, A. A. The association of girth measurements with disease in 32,856 women. Am. J. Epidemiol., 119: 71–80, 1984.
47. Beynen, A. C., and Katan, M. B. Why do polyunsaturated fatty acids lower serum cholesterol? Am. J. Clin. Nutr., 42: 560–563, 1985.
48. Nestel, P. J., Connor, W. E., Reardon, M. F., Connor, S., Wong, S., and Boston, R. Suppression by diets rich in fish oil of very low density lipoprotein production in men. J. Clin. Invest., 74: 82–89, 1984.
49. Bronsgeest-Schoute, H. C., von Gent, C. M., Luten, J. B., and Ruiter, A. The effect of various intakes of w3 fatty acids on the blood lipid composition in healthy human subjects. Am. J. Clin. Nutr., 34: 1752–1757, 1981.
50. Zak, A., Zeman, M., Hrabak, P. O., Svarcova, H., and Mares, P. Changes in the glucose tolerance and insulin secretion in hypertriglyceridemia: effects of dietary n-3 fatty acids. Nutr. Rep. Int., 39: 235–242, 1989.
51. Kasim, S. E., Stern, B., Khilnani, S., McLin, P., Baciorowski, S., and Jen, K. L. C. Effects of ω-3 fish oils on lipid metabolism, glycemic control, and blood pressure in type-II diabetic patients. J. Clin. Endocrinol. Metab., 67: 1–5, 1988.
52. Lardinois, C. K. The role of ω-3 fatty acids on insulin secretion and insulin sensitivity. Med. Hypotheses, 24: 243–248, 1984.
53. Lauber, H., Wallace, P., Griver, K., and Brechtel, G. Adverse metabolic effect of ω-3 fatty acids in non-insulin dependent diabetes mellitus. Ann. Intern. Med., 706: 663–668, 1988.
54. Schectman, G., Kaul, S., and Kissebah, A. H. Effect of fish oil concentration on lipoprotein composition in NIDDM. Diabetes, 37: 1567–1573, 1988.
55. Friday, K. E., Childs, M. T., Tsunehara, C. H., Fujimoto, W. Y., Bierman, E. L., and Ensinck, J. W. Elevated plasma glucose and lowered triglyceride levels from ω-3 fatty acid supplementation in type II diabetes. Diabetes Care, 72: 276–281, 1989.
56. Hendra, T. J., Britton, M. E., Roper, D. R., Wagaine-Twabwe, D., Jeremy, J. Y., Dandona, P., Haines, A. P., and Yudkin, J. S. Effects of fish oil supplements with NIDDM subjects. Diabetes Care, 73: 821–829, 1990.
57. Huttunen, J. K., Lansimies, E., Voutilainen, E., Ehnholm, E., Hietanen, E., Pentilla, I., Siltonen, B., and Rauramaa, R. Effect of moderate physical exercise on serum lipoproteins: a controlled clinical trial with special reference to serum high-density lipoproteins. Circulation, 60: 1220–1229, 1979.
58. Committee on Diet and Health. Diet and Health: Implications for Reducing Chronic Disease Risk, pp. 139–158. Washington DC: National Academy Press, 1989.
59. Cooper, K. H., Pollock, M. L., Martin, R. P., White, S. R., Linnerud, C., and Jackson, A. Physical fitness levels vs selected coronary risk factors. JAMA, 236: 166–169, 1976.
60. Montoge, H. J., Block, W. D., Metzner, H. L., and Keller, J. B. Habitual physical activity and serum lipids: males age 16-64 in a total community. J. Chron. Dis., 29: 697–709, 1976.
61. Nikkila, E. A., Kussi, T., and Myllynen, P. High density lipoprotein and apolipoprotein A-1 during physical inactivity. Artherosclerosis, 37: 457–462, 1980.
62. Kussi, T., Nikkila, E. A., Saarinen, P., Varjo, P., and Laitinen, L. A. Plasma high density lipoproteins HDL2, HDL3 and postheparin plasma lipases in relation to parameters of physical fitness. Artherosclerosis, 41: 209–219, 1982.
63. Hartung, G. H., Foreyt, J. P., Mitchell, R. E., Vlasek, I., and Gotto, A. M. Relation of diet to high-density-lipoprotein cholesterol in middle-aged marathon runners, joggers and inactive men. N. Engl. J. Med., 302: 357–361, 1980.
64. Wood, P. D., and Haskell, W. L. The effect of exercise on plasma high density lipoproteins. Lipids, 74: 417–427, 1979.
65. Huttunen, J. K., Lansimies, E., Voutilainen, E., Ehuholm, C., Hietanen, E., Pentilla, I., Siitonen, O., and Rauramaa, R. Effect of moderate physical exercise on serum lipoproteins. Circulation, 60: 1220–1229, 1979.
66. Blairs, N., Cooper, K. H., Gibbons, L. W., Gettman, L. R., Lewis, S., and Goodyear, N. Changes in coronary heart disease risk factors associated with increased treadmill time in 753 men. Am. J. Epidemiol., 118: 352–359, 1983.
67. Lipson, L. C., Bonow, R. O., Schafer, E. J., Brewer, H. B., and Lindgren, T. Effect of exercise conditioning on plasma high density lipoproteins and other lipoproteins. Artherosclerosis, 37: 529–538, 1980.
68. Rose, G., Blackburn, H., Keys, A., Kannel, W. B., Paul, O., Reid, D. D., and Stamler, J. Colon cancer and blood-cholesterol. Lancet, 7: 181–183, 1974.
69. Austin, M. A. Plasma triglyceride and coronary heart disease. Arterioscler. Thromb., 11: 2–14, 1991.
70. Pyoraia, K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care, 2: 131–141, 1979.
71. Ducimetiere, P., Eschwege, E., Papoz, L., Richard, J. L., Claude, J. R., and Rosselin, G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia, 79: 205–210, 1980.
72. Welborn, T. A., and Wearne, K. Coronary heart disease incidence and cardiovascular disease mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care, 2: 154–160, 1979.
73. Committee on Diet and Health. Diet and Health: Implications for Reducing Chronic Disease Risk, p. 170. Washington DC: National Academy Press, 1989.
74. Phillips, R. Role of life-style and dietary habits in risk of cancer among Seventh-day Adventists. Cancer Res., 35: 3215–3222, 1975.
75. Manousos, O., Day, N. E., Trichopoulos, D., Gerovassilis, G., and Tzonou, A. Diet and colorectal cancer: a case-control study in Greece. Int. J. Cancer, 32: 155–161, 1983.
76. Slavin, J. L., Lampe, J. W., Potter, J. D., and Lipkin, M. Cell proliferation in rectal biopsies collected from normal subjects consuming defined diets differing in dietary fiber content. J. Nutr., in press, 1994.
77. Stamp, D., Zhang, X. M., Medline, A., Bruce, W. R., and Archer, M. C. Sucrose enhancement of early steps of colon cancer carcinogenesis in mice. Carcinogenesis (Lond.), 14: 777–779, 1993.
78. Caderni, G., Bianchini, F., Mancina, A., Spagnesi, M. T., and Dolara, P. Effect of dietary carbohydrates on the growth of dysplastic crypt foci in the colon of rats treated with 1,2-dimethylhydrazine. Cancer (Phila.), 57: 3721–3725, 1991.
79. Lipkin, M. Biomarkers of increased susceptibility to gastrointestinal cancer: new applications to studies of cancer prevention in human subjects. Cancer Res., 48: 235–245, 1988.
80. Deschner, E. E., and Lipkin, M. Proliferative patterns in colonic mucosa in familial polyposis. Cancer (Phila.), 35: 413–418, 1975.
81. Romagnoli, P., Filipponi, F., Bandettini, L., and Brugnols, D. Increase of mitotic activity in the colonic mucosa of patients with colorectal cancer. Dis. Colon Rect., 27: 305–308, 1984.
82. Deschner, E. E., Winawer, S. J., Katz, S., and Kahn, E. Proliferative defects in ulcerative colitis patients. Cancer Invest., 7: 41–47, 1983.
83. Tepstra, O. T., van Blaukenstein, M., Decs, J., and Eilers, C. A. M. Abnormal patterns of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology, 92: 704–708, 1987.
84. Lipkin, M., Enker, W. E., and Winawer, S. J. Tritiated-thymidine labelling of rectal epithetical cells in “non-prep” biopsies of individuals at increased risk for colonic neoplasia. Cancer Lett., 37: 153–167, 1987.
85. Bird, R. P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett., 37: 147–151, 1987.
86. McLennan, E. A., and Bird, R. P. Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res., 48: 6187–6192, 1988.
87. Tudek, B., Bird, R. P., and Bruce, W. R. Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Res., 49: 1236–1240, 1989.
88. Day, D. W., and Morson, B. C. The adenoma-carcinoma sequence. In: C. Morson (ed.), The Pathogenesis of Colorectal Cancer, pp. 58–71. Philadelphia: W. B. Saunders, 1978.
89. Correa, P. Epidemiology of polyps and cancer. In: B. C. Morson, (ed.), The Pathogenesis of Colorectal Cancer, pp. 126–152. Philadelphia: W. B. Saunders, 1978.
90. Kashtan, H., Stern, H. S., Jenkens, D. J. A., Jenkens, A. L., Thompson, L. U., Hay, K., Marcon, N., Minkin, S., and Bruce, W. R. Effect of manipulating colonic fermentation on markers of colorectal cancer risk. Am. J. Clin. Nutr., 50: 723–728, 1992.
91. Eyssen, G. E. M., Bright-See, E., Bruce, W. R., and Jazmaji, V. A randomized trial of a low fat high fibre diet in the recurrence of colorectal polyps. J. Clin. Epidemiol., 47: 525–536, 1994.
92. Eyssen, G. E. M. The epidemiology of colorectal cancer revisited: are serum triglycerides and plasma glucose associated with risk? The Application of Molecular Biology to Cancer Control: New Avenues for Epidemiologic Research. Montreal: Health Canada, 1994.
93. Eyssen, G. E. M. Are serum triglycerides and plasma glucose associated with the risk of colorectal cancer? Washington DC: American Society of Preventive Oncology, 1994.
94. Committee on Diet and Health. Diet and Health: Implications for Reducing Chronic Disease Risk, pp. 159–258. Washington DC: National Academy Press, 1989.
95. Stadler, J., Yeung, K. S., Furrer, R., Marcon, N., Himal, H. S., and Bruce, W. R. Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer. Cancer Lett., 38: 315–320, 1988.
96. Yueng, K. S., McKeown-Eyssen, G. E., Li, G. F., Glazer, E., Hay, K., Child, P., Gurgin, V., Zhu, S. L., Baptista, J., Aloe, M., Mee, D., Jazmaji, V., Austin, D. F., Li, C. C., and Bruce, W. R. Comparisons of diet and biochemical characteristics of stool and urine between Chinese populations with low and high colorectal cancer rates. J. Natl. Cancer Inst., 83: 46–50, 1991.
97. Rafter, J. J., Child, P., Anderson, A. M., Alder, R., Eng, V., and Bruce, W. R. Cellular toxicity of fecal water depends on diet. Am. J. Clin. Nutr., 45: 559–563, 1987.
98. Rafter, J. J., Eng, V. W. S., Furrer, R., Medline, A., and Bruce, W. R. Effect of calcium and pH on the mucosal damage produced by deoxycholic acid in the rat colon. Gut, 27: 1320–1329, 1986.
99. Narisawa, T., Magadia, N. E., Weisburger, J. H., and Wynder, E. L. Promoting effects of bile acids on colon carcinogenesis after intra-rectal instillation of N-methyl-N-nitrosoguanine in rats. J. Natl. Cancer Inst., 53: 1093–1095, 1974.
100. Sarwal, A. N., Cohen, B. I., Raicht, R. F., Takahashi, M., and Fazzini, E. Effects of dietary administration of chenodeoxycholate on N-methyl-N-nitrosourea induced colon cancer in rats. Biochem. Biophys. Acta., 574: 423–432, 1979.
101. Angelin, B., and Einarsson, K. Bile acids and lipoprotein metabolism. In: Grundy, S. M. (ed.), Bile Acids and Artherosclerosis, pp. 41–66. New York: Raven Press, 1986.
102. Kessler, I. I. Cancer and diabetes mellitus a review of the literature. J. Chron. Dis., 23: 579–600, 1971.
103. Marks, P. A., and Bishop, J. S. The glucose metabolism of patients with malignant disease and of normal subjects as studied by means of an intravenous glucose tolerance test. J. Clin. Invest., 36: 254–264, 1957.
104. Bishop, J. S., and Marks, P. A. Studies on carbohydrate metabolism in patients with neoplastic disease. II. Response to insulin administration. J. Clin. Invest., 38: 668–672, 1959.
105. Weisenfeld, S., Hecht, A., and Goldner, M. G. Tests of carbohydrate metabolism in carcinomatosis. Cancer (Phila.), 15: 18–27, 1962.
106. MacBeth, R. A. L., and Bekesi, J. G. Plasma glycoproteins in various disease states including carcinoma. Cancer Res., 22: 1170–1176, 1962.
107. Rohdenberg, G. L., Bernhard, A., and Krehbiel, O. Sugar tolerance in cancer. JAMA, 72: 1528–1530, 1919.
108. Levine, W., Dryer, A. R., Shekelle, R. B., Schoenberger, J., and Stamler, J. Post-load glucose and cancer mortality in middle-aged men and women. Am. J. Epidemiol., 131: 254–262, 1990.
109. Smith, G. D., Egger, M., Shipley, M. J., and Marmot, M. G. Post-challenge glucose concentration, impaired glucose tolerance, diabetes and cancer mortality in men. Am. J. Epidemiol., 136: 1110–1114, 1992.
110. Wilson, E. B., and Maher, H. C. Cancer and tuberculosis with some comments on cancer and other diseases. Am. J. Cancer, 16: 227–250, 1932.
111. Glickman, A. S., and Rawson, R. W. Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer (Phila.), 9: 1127–1134, 1956.
112. O’Mara, B. A., Byers, T., and Schoenfeld, E. Diabetes mellitus and cancer risk: a multisite case-control study. J. Chron. Dis., 38: 435–441, 1985.
113. Adami, H. O., McLaughlin, J., Ekbom, A., Berne, C., Silverman, D., Hacker, D., and Persson, I. Cancer risk in patients with diabetes mellitus. Cancer Causes Control, 2: 307–314, 1991.
114. Ragozzino, M., Melton, L. J., Chu, C. P., and Palumbo, P. J. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J. Chron. Dis., 35: 13–19, 1982.
115. Kessler, I. I. Cancer mortality among diabetics. J. Natl. Cancer Inst., 44: 673–686, 1970.
116. Kessler, I. I. Mortality experience of diabetic patients, a twenty-six year follow-up. Am. J. Med., 51: 715–724, 1971.
117. Kruis, W., Forstmaier, G., Scheurlen, C., and Stellaard, F. Effect of diets low and high in refined sugars on gut transit, bile acid metabolism and bacterial fermentation. Gut, 32: 367–371, 1991.
118. Reaven, G. M. The role of insulin resistance in human disease. The Banting Lecture 1988. Diabetes, 37: 1595–1607, 1988.
119. Korc, M. Growth factors and oncogenes. Regul. Pept. Lett., 2: 7–11, 1990.
120. Wong, M., and Holdaway, I. M. Insulin binding by normal and neoplastic colonic tissues. Int. J. Cancer, 35: 335–341, 1985.
121. Cullen, K. J., Yee, D., and Rosen, N. Insulin-like growth factors in human malignancy. Cancer Invest., 9: 443–454, 1991.
122. Salamon, E. A., Luo, J., and Murphy, L. J. The effect of acute and chronic insulin administration on insulin-like growth factor-l expression in the pituitary-intact and hypophysectomised rat. Diabetologia, 32: 348–353, 1989.
123. Culouscou, J. M., and Shoyah, M. Purification of a colon cancer cell growth inhibitor and its identification as an insulin-like growth factor binding protein. Cancer Res., 51: 2813–2819, 1991.
124. Bruning, P. F., Bonfrer, J. M. G., Van Noord, P. A. H., Hart, A. A. M., Jing-Bakker, M. D. E., and Nooyen, W. J. Insulin resistance and breast cancer risk. Int. J. Cancer, 52: 511–516, 1992.
125. Dodge, B. G., O’Neal, M. A., Chang, J. P., and Griffin, A. G. Effects of adrenocorticotropic and insulin on carcinogenesis in hypophysectomized rats. J. Natl. Cancer Inst., 27: 817–825, 1961.
126. Lorenzi, M., Montisano, D. F., Toledo, S., and Barvieux, A. High glucose induces DNA damage in cultured human endothelial cells. J. Clin. Invest., 77: 322–325, 1986.
127. Schade, D. S., Santigao, J. V., Skyler, J. S., and Rizza, R. A. Intensive Insulin Therapy. Excerpta Med., 23–35, 1983.
128. Bristol, J. B., and Williamson, R. C. N. Large bowel growth. In: J. M. Poliak, S. R. Bloom, N. A. Wright, and A. G. Butler, (eds.), Basic Science in Gastroenterology, pp. 307–316. Ware, Herts, UK: Glaxo Group Research Ltd., 1984.
129. Townsend, C. M. Peptides and gastrointestinal cancer growth. Regul. Pept. Lett., 2: 12–15, 1990.
130. Upp, J. R., Olson, D., and Poston, G. J. Inhibition of growth of two human pancreatic adenocarcinomas in vitro by somatostatin analog SMS 201-995. Am. J. Surg., 755: 29–35, 1988.
131. Jenkins, D. J. A., Leeds, A. R., Gassull, M. A., Cochet, B., and Alberti, K. G. M. M. Decrease in postprandial insulin and glucose concentrations by guar and pectin. Am. Intern. Med., 86: 20–23, 1977.
132. Jenkins, D. J. A., Leeds, A. R., Gassull, M. A., Wolever, T. M. S., Goff, D. V., Alberti, K. G. M. M., and Hockaday, T. D. R. Unabsorbable carbohydrate and diabetes: decreased post-prandial hyperglycaemia. Lancet, 2: 172–174, 1976.
133. Beck-Nielsen, H., Pederson, O., and Lindskov, O. Impaired cellular insulin binding and insulin sensitivity by high-fructose feeding in normal subjects. Am. J. Clin. Nutr., 33: 273–278, 1980.
134. Roediger, W. E. W. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut, 21: 793–798, 1980.
135. Cummings, J. H., and Englyst, H. N. Fermentation in the human large intestine and available substrates. Am. J. Clin. Nutr., 45: 1243–1255, 1987.
136. Roediger, W. E. W. The effect of bacterial metabolites on nutrition and function of the colonic mucosa: symbiosis between bacteria and man. In: H. Kasper and H. Goebell (eds.), Colon and Nutrition, pp. 11–13. Lancaster, PA: MTP Press Ltd., 1982.
137. Kruh, J. Effects of sodium butyrate, a new pharmacological agent on cells in culture. Mol. Cell. Biochem., 42: 65–82, 1982.
138. Smith, P. J. n-Butyrate alters chromatin accessibility to DNA repair enzymes. Carcinogenesis (Lond.), 7: 423–429, 1986.
139. Kim, Y. S., Tsao, D., Morita, A., and Bella, A. Effect of sodium butyrate on three human colorectal adenocarcinoma cell lines in culture. In: R. A. Malt and R. C. N. Williamson, (eds.), Colonic Carcinogenesis, pp. 317–323. Falk Symposium 31, Lancaster: MTP Press Ltd., 1982.
140. Jass, J. R., Strudley, I., and Faludy, J. Histochemistry of epithelial metaplasia and dysplasia in human stomach and colorectum. Scand. J. Gastro Gastroenterol., 104 (suppl.): 109–130, 1984.
141. Jass, J. R. Diet, butyric acid and differentiation of gastrointestinal tract tumours. Med. Hypotheses, 18: 113–118, 1985.
142. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 67: 759–767, 1990.
143. McMichael, A. J., Jensen, O. M., Parkin, D. M., and Zaridze, D. G. Dietary and endogenous cholesterol and human cancer. Epidemiol. Rev., 6: 192–216, 1984.
144. Sorlie, P. D., and Feinleib, M. The serum cholesterol-cancer relationship: an analysis of time trends in the Framingham study. J. Natl. Cancer Inst., 69: 989–996, 1982.
145. Miller, S. R., Tariter, P. I., Papatestas, A. E., Slater, G., and Aufses, A. H. Serum cholesterol and colon cancer. J. Natl. Cancer Inst., 67: 297–300, 1981.
146. Stemmerman, G. N., Normura, A. M. Y., Heibrun, L. K., Pollack, E. S., and Kagan, A. Serum cholesterol and colon cancer incidence in Hawaiian Japanese men. J. Natl. Cancer Inst., 67: 1179–1182, 1981.
147. Jacobs, D., Blackburn, H., Higgins, M., Reed, D., Iso, H., McMillan, G., Neaton, J., Nelson, J., Potter, J., Rifkind, B., Rossouw, J., Shekelle, R., and Yusuf, S. Report of the conference on low blood cholesterol: mortality associations. Circulation, 86: 1046–1060, 1992.
148. De Fronzo, R. D., and Ferrannini, E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and artherosclerotic cardiovascular disease. Diabetes Care, 14: 173–194, 1991.